DSG Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:DSG Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10927
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
DSG Inc (DSG) is a provider of eClinical software solutions. The company offers software products such as eCaseLink EDC, eClinDirect CTMS, eCaseLink.Me ePRO, DSG Drug Safety, eCaseLink IRT, DSG Designer, CaseXport, CaseView Imaging, and others. Its services include data management, technology transfer, technical support, project management, clinical trials training, document management, data integration, and secure web hosting services. DSG caters its solutions for pharmaceutical, medical device and life sciences industries. The company operates through its offices located in Malvern and Oaks, the US; Noida and Bangalore, India and Taipei, Taiwan. DSG is headquartered in Malvern, Pennsylvania, the US.

DSG Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
DSG Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DSG Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DSG Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DSG Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DSG Inc, Medical Devices Deals, 2012 to YTD 2018 9
DSG Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DSG Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
DSG Enters into Licensing Agreement with Integrium 11
Orbus Therapeutics Enters into Agreement with DSG 12
Licensing Agreements 13
Opko Health Enters into Licensing Agreement with DSG 13
DSG Inc – Key Competitors 14
DSG Inc – Key Employees 15
DSG Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Other Significant Developments 17
Jun 25, 2018: Enhancing the EDC Experience with eCaseLink 10 from DSG 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
DSG Inc, Pharmaceuticals & Healthcare, Key Facts 2
DSG Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DSG Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
DSG Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DSG Inc, Deals By Therapy Area, 2012 to YTD 2018 8
DSG Inc, Medical Devices Deals, 2012 to YTD 2018 9
DSG Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
DSG Enters into Licensing Agreement with Integrium 11
Orbus Therapeutics Enters into Agreement with DSG 12
Opko Health Enters into Licensing Agreement with DSG 13
DSG Inc, Key Competitors 14
DSG Inc, Key Employees 15
DSG Inc, Other Locations 16
DSG Inc, Subsidiaries 16

List of Figures
DSG Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
DSG Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
DSG Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
DSG Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
DSG Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
DSG Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
DSG Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
DSG Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[DSG Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Intellipharmaceutics International Inc (IPCI):企業の財務・戦略的SWOT分析
    Intellipharmaceutics International Inc (IPCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Neuren Pharmaceuticals Ltd (NEU):企業の財務・戦略的SWOT分析
    Summary Neuren Pharmaceuticals Ltd (Neuren Pharma) is a biopharmaceutical company that develops drugs for brain injury, neurodevelopmental and neurodegenerative disorders. The company provides pipeline products such as trofinetide and NNZ-2591. Its trofinetide has a pharmacokinetic profile, which is …
  • Daqo New Energy Corp (DQ)-エネルギー分野:企業M&A・提携分析
    Summary Daqo New Energy Corp (Daqo Cayman) is a manufacturer of polysilicon and solar wafers. Through tolling agreements, the company also offers wafer original equipment manufacturer (OEM) services to external customers. It sells its products to solar cell and solar module manufacturers. Daqo Cayma …
  • Damco International B.V.:企業の戦略・SWOT・財務分析
    Damco International B.V. - Strategy, SWOT and Corporate Finance Report Summary Damco International B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務分析
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Dalian Wanda Group:企業の戦略・SWOT・財務情報
    Dalian Wanda Group - Strategy, SWOT and Corporate Finance Report Summary Dalian Wanda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NovaMedica LLC-製薬・医療分野:企業M&A・提携分析
    Summary NovaMedica LLC is a drug company that offers gastroenterology and ophthalmology products. The company offers pharmaceutical and other medical products such as diagnostic equipment, medical devices and technologies designed to provide a solution for range of interrelated problems. It provides …
  • ProMIS Neurosciences Inc (PMN)-医療機器分野:企業M&A・提携分析
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd. is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps …
  • PositiveID Corp (PSID):企業の財務・戦略的SWOT分析
    Summary PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products in …
  • Himachal Futuristic Communications Ltd (HFCL):企業の財務・戦略的SWOT分析
    Summary Himachal Futuristic Communications Ltd (HFCL) is a manufacturer of telecommunication equipment, optical fiber cables, and intelligent power systems. The company’s optical fiber cables comprise aerial, armoured, FTTx, micro and unarmoured cables. It also provides microwave radios, GPON and so …
  • Turisthotel d.d.:企業の戦略・SWOT・財務情報
    Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report Summary Turisthotel d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Caltex Australia Ltd (CTX):石油・ガス:M&Aディール及び事業提携情報
    Summary Caltex Australia Ltd (Caltex) is a supplier of transport fuels and convenience retailer. The company purchases, refines, distributes and markets petroleum products. It supplies liquefied petroleum gas (LPG), petrol, diesel, jet fuel, lubricants, greases, fuel oil and specialty products. The …
  • Antibe Therapeutics Inc (ATE):医療機器:M&Aディール及び事業提携情報
    Summary Antibe Therapeutics Inc (Antibe) is a biotech company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercializes novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen deriv …
  • PTT Public Company Limited:戦略・SWOT・企業財務分析
    PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary PTT Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • National Comprehensive Cancer Network-製薬・医療分野:企業M&A・提携分析
    Summary National Comprehensive Cancer Network (NCCN) is a contract research organization that offers clinical services. The organization offers research and medical information to help patients and health professionals related to cancer care. It provides subscriptions and products which include NCCN …
  • Duke Energy Corp:企業の発電所・SWOT分析2018
    Duke Energy Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (e …
  • Select Medical Holdings Corporation:企業の戦略・SWOT・財務情報
    Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report Summary Select Medical Holdings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • EOG Resources Inc (EOG):石油・ガス:M&Aディール及び事業提携情報
    Summary EOG Resources Inc (EOG) is an independent upstream oil and gas company. The company, along with its subsidiaries, explores for, develops and produces crude oil and natural gas. EOG has operations in the US, Canada, Trinidad, the UK and China. Its holds licenses for assets in in Eagle Ford, B …
  • AIA Group Limited:企業の戦略・SWOT・財務情報
    AIA Group Limited - Strategy, SWOT and Corporate Finance Report Summary AIA Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Steelcase Inc (SCS):企業の財務・戦略的SWOT分析
    Steelcase Inc (SCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆